News
1mon
MyChesCo on MSNEndo, Inc. to Sell International Pharmaceuticals Business to Knight TherapeuticsMALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced a definitive agreement to divest its International Pharmaceuticals ...
The city of Decatur has so far received $1.79 million in opioid settlement money from pharmaceutical companies, and the state attorney general recently advised that it must be spent on opioid recovery ...
The generic pharmaceuticals businesses of both legacy companies will be combined with Endo’s sterile injectables business. That combined business will be spun out at a later date, subject to ...
Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals business, primarily operated through Canada ...
Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals business, primarily operated through ...
Net Leverage of Approximately 2.3x Expected at Close Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results